Hudson Bay Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-475,000
| Closed | -$19.4M | – | 903 |
|
|
2024
Q2 | $19.4M | Buy |
475,000
+251,926
| +113% | +$10.3M | 0.09% | 92 |
|
|
2024
Q1 | $9.43M | Buy |
223,074
+135,674
| +155% | +$5.73M | 0.05% | 146 |
|
|
2023
Q4 | $3.71M | Buy |
87,400
+37,400
| +75% | +$1.59M | 0.02% | 300 |
|
|
2023
Q3 | $1.09M | Buy |
+50,000
| New | +$1.09M | 0.01% | 468 |
|
|
2023
Q2 | – | Sell |
-40,000
| Closed | -$976K | – | 947 |
|
|
2023
Q1 | $976K | Sell |
40,000
-10,000
| -20% | -$244K | 0.01% | 550 |
|
|
2022
Q4 | $1.58M | Buy |
50,000
+5,000
| +11% | +$158K | 0.02% | 600 |
|
|
2022
Q3 | $1.27M | Buy |
+45,000
| New | +$1.27M | 0.01% | 784 |
|
|
2020
Q4 | – | Sell |
-153,984
| Closed | -$1.61M | – | 721 |
|
|
2020
Q3 | $1.61M | Buy |
+153,984
| New | +$1.61M | 0.02% | 367 |
|